FILLER LINE.

Class III intradermal injectable medical devices CE 0373

Formula with European Patent No. 21202527.4

Skin-F ® 22

In 1-mL syringe, contains 22 mg/ml cross-linked sodium hyaluronate in sterile buffered water with added glycine and proline.

Skin-F ® 24

In 1-mL syringe, contains 24 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline.

Skin-F ® 26

In 1-mL syringe, contains 26 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline.

Skin-F ® MAN 22

In 1-mL syringe, contains 22 mg/ml cross-linked sodium hyaluronate in sterile buffered water with added glycine and proline.

Skin-F ® MAN 24

In 1-mL syringe, contains 24 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline.

Skin-F ® MAN 26

In 1-mL syringe, contains 26 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline.

Fillervit ® F 22

In 1-mL syringe, contains 22 mg/ml cross-linked sodium hyaluronate in sterile buffered water with added glycine and proline.

Fillervit ® F 24

In 1-mL syringe, contains 24 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline.

Fillervit ® F 26

In 1-mL syringe, contains 26 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline.

THIS PAGE IS INTENDED ONLY FOR HEALTH CARE PROFESSORS

By clicking "CONFIRM", you declare under your own responsibility that you are a physician or other health professional.

CONFIRM CANCEL